BRCA1 and neoplasm: Because tumour cells with deficient homologous repair mechanisms are more sensitive to PARPi, including tumours with BRCA1/2 mutations and BRCAness, we analysed mutations in a panel of 69 genes involved in DNA repair (Supplementary Data 1 and 2).